Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Real-world Study of Rimegepant for the Preventive Treatment in Female Migraine Patients

NCT06728345 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.

NCT NCT06728345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06728345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Real-world Study of Rimegepant for the Preventive Treatment in Female Migraine Patients
Lead sponsor
The First Affiliated Hospital of Soochow University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine prophylaxis